Daniel Loeb's position in Acorda Therapeutics is currently worth $5.5 Thousand. That's 0.00% of their equity portfolio (31st largest holding). The investor owns Inf% of the outstanding Acorda Therapeutics stock. Daniel Loeb started to build up the position in Acorda Therapeutics in Q3 2006 and continued to invest until Q1 2007. Since then they sold 10.7 Thousand shares. The investor's estimated purchase price is $133 Thousand, resulting in a loss of 96%.